|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/131 | (2006.01) |
| A61K 38/1816 | (2013.01) | ||
| A61K 31/132 | (2006.01) | ||
| A61K 38/47 | (2013.01) | ||
| A61K 31/215 | (2006.01) | ||
| A61K 38/4846 | (2013.01) | ||
| A61K 31/56 | (2006.01) | ||
| A61K 38/57 | (2013.01) | ||
| A61K 9/127 | (2006.01) | ||
| A61K 48/00 | (2013.01) | ||
| A61K 38/47 | (2006.01) | ||
| A61K 31/713 | (2013.01) | ||
| A61K 9/0019 | (2013.01) | ||
| A61P 3/08 | (2006.01) | ||
| C12N 9/64 | (2006.01) | ||
| A61K 9/0073 | (2013.01) | ||
| A61K 9/1271 | (2013.01) | ||
| A61K 9/1272 | (2013.01) | ||
| C07K 14/505 | (2013.01) | ||
| C07K 14/8125 | (2013.01) | ||
| C12N 9/2465 | (2013.01) | ||
| C12N 9/644 | (2013.01) | ||
| C12N 15/52 | (2013.01) | ||
| C12Y 302/01022 | (2013.01) | ||
| C12Y 304/21022 | (2013.01) | ||
| A61P 1/16 | (2018.01) | ||
| A61P 3/00 | (2018.01) | ||
| A61P 5/00 | (2018.01) | ||
| A61P 7/06 | (2018.01) |
| (11) | Number of the document | 3586861 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19172992.0 |
| Date of filing the European patent application | 2012-06-08 | |
| (97) | Date of publication of the European application | 2020-01-01 |
| (45) | Date of publication and mention of the grant of the patent | 2022-02-09 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201161494881 P | 2011-06-08 | US |
| (72) |
GUILD, Braydon Charles , US
DEROSA, Frank , US
HEARTLEIN, Michael , US
|
| (73) |
Translate Bio, Inc. ,
29 Hartwell Avenue, Lexington, MA 02421,
US
|
| (54) | LIPID NANOPARTICLE COMPOSITIONS AND METHODS FOR MRNA DELIVERY |
| LIPID NANOPARTICLE COMPOSITIONS AND METHODS FOR MRNA DELIVERY |